FDA Inspection 1225652 — Eurofins BioPharma Product Testing Toronto, Inc.
The FDA completed an inspection of Eurofins BioPharma Product Testing Toronto, Inc. on November 15, 2023 in North York. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 15, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- North York (Canada)